A new gene therapy has shown promise in treating a form of T-cell leukemia that is considered incurable. The therapy, which involves the use of "ready-made" T-cells, has been tested in early trials and has reportedly reversed the disease in some patients. Details of the treatment and its outcomes are emerging from various institutions, including King's College Hospital and University College London.